Trials / Completed
CompletedNCT00446563
Efficacy and Safety of Valsartan in Combination With Amlodipine Compared to Losartan Plus Hydrochlorothiazide in Patients With Hypertension and Left Ventricular Hypertrophy
An Open-label, Randomized, Parallel Group Study Comparing the Efficacy and Safety of Amlodipine in Combination With Valsartan Compared to Losartan in Combination With Hydrochlorothiazide Given for 52 Weeks on the Regression of Left Ventricular Hypertrophy in Patients With Mild to Moderate Hypertension
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the safety and efficacy of amlodipine plus valsartan in patients with hypertension and left ventricular hypertrophy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Valsartan | 160 mg film coated tablets taken orally once daily in the morning. |
| DRUG | Amlodipine | 5 mg or 10 mg tablets taken orally once daily in the morning. |
| DRUG | Hydrochlorothiazide | 12.5 mg or 25 mg tablets taken orally once daily in the morning. |
| DRUG | Losartan | 100 mg tablets taken orally once daily in the morning. |
Timeline
- Start date
- 2007-03-01
- Primary completion
- 2010-03-01
- Completion
- 2010-03-01
- First posted
- 2007-03-13
- Last updated
- 2011-05-11
- Results posted
- 2011-04-27
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00446563. Inclusion in this directory is not an endorsement.